Effective Use of Resources
The NHS belongs to us all. It is there to improve our health and
well-being, support us to keep mentally and physically well, to get better when we are ill and, when we
cannot fully recover to stay as well as we can to the end of our lives.
To make sure that we can provide the best care for the maximum number of
people it is vital that we make every penny count.
This means funding treatments that have been demonstrated to work and
where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that
are not of great health benefit uses up resources that could be spent on really
making a difference elsewhere.
As happens in other parts of the country, we may decide that a treatment
or procedure should not be routinely funded because:
There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).
The Effective Use of Resources (EUR) Treatment
Policies below lists those treatments/procedures that are not funded or where
funding will only be made available if specific criteria are met. The
Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR
policies and has a programme of work to develop new GM EUR policies. This
work helps to ensure that people across the whole of GM are able to access
these treatments in a fair and equitable manner.
important to remember that while the NHS does not want to carry out
treatments/procedures which have little health benefit in general, there may be
overwhelming health benefits for an individual patient. In these cases, a
clinician, on behalf of a patient, will explain the exceptional circumstances
and request that these are considered through the GM EUR process, where it will
be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions
on an individual case by case basis.
The GM EUR process for requesting funding on an individual patient basis
is detailed in the GM EUR Operational Policy below. This process is applied consistently by
all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our
Individual Funding Request Panel can also be found below.
The initial decision to make a request for funding will be taken in conjunction
with the clinician looking after your condition.
Effective Use of Resources (EUR) Team:
process or funding requests: Tel: 0161 212 6250 / Email: email@example.com
EUR policy development: Tel: 0161 212
6212 / Email: firstname.lastname@example.org
Advice & Liaison Service (PALS): Tel: 0161 212 6270 / Email: email@example.com
Seeking medical treatment abroad
an NHS patient, you have the right to receive treatment anywhere in
the European Economic Area (EEA), provided that the treatment is funded by
the NHS. Our EUR policies above
also apply to treatment accessed in Europe. Further information regarding
accessing medical treatment in Europe can be found on the NHS
Treatments which are not the funding responsibility
of CCGs in England
There are a number
of treatments and conditions which are funded directly by NHS England, which
means that CCGs in England are not responsible for funding the care for
patients related to that particular treatment or condition. Further information regarding the
treatments and conditions funded by NHS England can be found on their website.